A study has revealed the mechanism of CRS in CAR-T therapy, where CAR-T recognizes target cells and releases perforin and granzyme B, activating the caspase3-GSDME pathway and leading to cell pyroptosis and CRS. This evidence concerns the gene PRF1 and congenital rubella syndrome.